Solara Active Pharma Sciences Limited (SOLARA.NS) NSE

Currency In INR

AD

Valuation

Market Cap18.77B
Enterprise Value25.13B
P/E Ratio87.6
PEG Ratio-0.01
Price/Sales Ratio2.12
Price/Book Ratio2.26
Enterprise/Revenue2.46
Enterprise/EBITDA16.03

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue13.69B
Revenue/Share319.35
Gross Profit3.66B
EBITDA1.87B
Net Income-74.1M
Diluted EPS-1.68

Balance Sheet

Total Cash709.1M
Total Cash/Share14.75
Total Debt5.91B
Total Debt/Equity0.41
Current Ratio1.32
Book Value Per Share299.28

Price History

52-Week Change22.13
52-Week High774
52-Week Low422
Moving Average 50 Days679.9
Moving Average 200 Days560.31

Statistics

Average Volume592,659
Shares Outstanding48.07M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor217:200
Last Split DateMay 15, 2024
AD